| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/15/2011 | US20110225672 Melon hybrid bucanero |
| 09/15/2011 | US20110225671 Plants and seeds of spring canola variety scv119103 |
| 09/15/2011 | US20110225670 Cotton variety 09r605b2r2 |
| 09/15/2011 | US20110225669 Cotton variety 09r615b2r2 |
| 09/15/2011 | US20110225668 Plants and seeds of spring canola variety scv152154 |
| 09/15/2011 | US20110225667 Cotton variety 09r798b2r2 |
| 09/15/2011 | US20110225666 Plants and seeds of corn variety cv165560 |
| 09/15/2011 | US20110225664 Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof |
| 09/15/2011 | US20110225663 Method for producing eukaryotic organisms with enhanced pathogen resistance and/or resistance to stress and eukaryotic transgenic organisms with enhanced pathogen resistance and/or resistance to stress |
| 09/15/2011 | US20110225662 Female specific insect expression system |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224406 Interleukin-9 receptor mutants |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224282 iRNA Agents Targeting VEGF |
| 09/15/2011 | US20110224281 Rna antagonists targeting hsp70-2 |
| 09/15/2011 | US20110224280 Pharmaceutical Composition Comprising Anti PCSK9 Oligomers |
| 09/15/2011 | US20110224279 Anticancer agent |
| 09/15/2011 | US20110224277 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110224097 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2 |
| 09/15/2011 | US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 09/15/2011 | US20110223671 Methods for using positively and negatively selectable genes in a filamentous fungal cell |
| 09/15/2011 | US20110223670 Ets2 and mesp1 generate cardiac progenitors from fibroblasts |
| 09/15/2011 | US20110223669 Method of efficiently establishing induced pluripotent stem cells |
| 09/15/2011 | US20110223668 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
| 09/15/2011 | US20110223665 ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223657 Trp/his exchange and kynurenin induced trp transport |
| 09/15/2011 | US20110223656 MicroRNAs and Uses Thereof |
| 09/15/2011 | US20110223641 Microbial engineering for the production of fatty acids and fatty acid derivatives |
| 09/15/2011 | US20110223636 Fluorescent protein and chromoprotein |
| 09/15/2011 | US20110223635 Method and Composition for Controlling Gene Expression |
| 09/15/2011 | US20110223628 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM |
| 09/15/2011 | US20110223609 Gene defects and mutant ALK kinase in human solid tumors |
| 09/15/2011 | US20110223592 Multiple fluorophore detector system |
| 09/15/2011 | US20110223584 Oligonucleotides For Detecting Human Papilloma Virus In A Test Sample |
| 09/15/2011 | US20110223217 Block copolymers and uses thereof |
| 09/15/2011 | US20110223204 Treatment of pain with gap junction modulation compounds |
| 09/15/2011 | US20110223189 Agent for treating leishmania infections |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223186 Clostridium toxin, and process for the preparation of immunogenic composition |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223176 Basigin binding proteins |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223173 Botulinum Neurotoxin A Receptor and the Use Thereof |
| 09/15/2011 | US20110223171 Methods and Compositions for the Diagnosis and Treatment of Cyclin A-1 Associated Conditions |
| 09/15/2011 | US20110223168 Ligand that has binding specificity for il-4 and/or il-13 |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223163 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 09/15/2011 | US20110223160 Compositions and methods relating to glucagon receptor antibodies |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223133 Therapeutic agent for hematopoietic tumors |
| 09/15/2011 | US20110223129 Chimeric immunoreceptor useful in treating human cancers |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223117 Alpha-glucanase and oral care composition containing the same |
| 09/15/2011 | US20110223107 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/15/2011 | US20110220570 Heavy metal remediation system |
| 09/15/2011 | CA2849668A1 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | CA2792910A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | CA2792546A1 Highly productive isopropyl alcohol-producing bacterium |
| 09/15/2011 | CA2792469A1 Methods of testing for intracellular pathogens |
| 09/15/2011 | CA2792118A1 Bluetongue virus recombinant vaccines and uses thereof |
| 09/15/2011 | CA2792117A1 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/15/2011 | CA2791944A1 Biological products: humanised agonistic anti-pd-1 antibodies |
| 09/15/2011 | CA2791930A1 Pd-1 antibody |
| 09/15/2011 | CA2791697A1 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2 |
| 09/15/2011 | CA2791474A1 Polypeptide having diterpene synthase activity |
| 09/15/2011 | CA2790949A1 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | CA2790778A1 Modified family 5 cellulases and uses thereof |
| 09/15/2011 | CA2790211A1 Polynucleotide molecules for gene regulation in plants |
| 09/14/2011 | EP2365335A2 Diagnostic method |
| 09/14/2011 | EP2365098A2 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 09/14/2011 | EP2365097A1 Nucleic acid probe-based assays for prokaryotic and eukaryotic organisms |
| 09/14/2011 | EP2365096A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/14/2011 | EP2365094A1 Antisense modulation of PTP1B expression |
| 09/14/2011 | EP2365093A2 Method for sequencing nucleic acid molecules |
| 09/14/2011 | EP2365090A1 Method for enhancing production of isoprenoid compounds |
| 09/14/2011 | EP2365089A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 09/14/2011 | EP2365088A2 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways |
| 09/14/2011 | EP2365087A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 09/14/2011 | EP2365086A1 Novel omega-3 fatty acid desaturase family members and uses thereof |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2365084A2 Construction of new variants of dextransucrase DSR-S by genetic engineering |
| 09/14/2011 | EP2365083A1 Lactic acid bacterial starter cultures and compositions thereof |
| 09/14/2011 | EP2365082A1 BVDV virus-like particles |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365080A1 Mcp-1 binding nucleic acids |
| 09/14/2011 | EP2365079A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2011 | EP2365078A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2011 | EP2365077A1 iRNA agents targeting VEGF |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365075A1 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness |
| 09/14/2011 | EP2365074A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365073A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365072A1 Recombinant dna for gene suppression |
| 09/14/2011 | EP2365071A1 Transformed soybean plant which stores vaccine, and use thereof |
| 09/14/2011 | EP2365070A1 Sesquiterpene synthases and methods of use |
| 09/14/2011 | EP2365069A1 Method of producing non-bovine chymosin and use hereof |
| 09/14/2011 | EP2365066A1 Laglidadg homing endonuclease variants having mutations in two functional subdominants und use thereof |